REGENERON PHARMACEUTICALS FDA Approval BLA 761097

BLA 761097

REGENERON PHARMACEUTICALS

FDA Drug Application

Application #761097

Documents

Label2019-08-21
Letter2018-10-01
Label2018-10-04
Review2018-10-30
Label2019-01-22
Letter2019-01-22
Letter2019-03-21
Label2020-06-26
Medication Guide2020-06-26
Letter2020-06-26
Letter2020-11-12
Label2020-11-13
Medication Guide2020-11-13
Label2021-02-09
Label2021-02-09
Medication Guide2021-02-09
Letter2021-02-10
Letter2021-02-10
Label2021-02-22
Medication Guide2021-02-22
Letter2021-02-23
Label2022-11-08
Medication Guide2022-11-08
Letter2022-11-09

Application Sponsors

BLA 761097REGENERON PHARMACEUTICALS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS350MG0LIBTAYOCEMIPLIMAB-RWLC

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2018-09-28PRIORITY
LABELING; LabelingSUPPL2AP2019-01-18STANDARD
LABELING; LabelingSUPPL3AP2020-11-10STANDARD
EFFICACY; EfficacySUPPL5AP2020-06-25STANDARD
EFFICACY; EfficacySUPPL7AP2021-02-22PRIORITY
EFFICACY; EfficacySUPPL8AP2021-02-09PRIORITY
EFFICACY; EfficacySUPPL9AP2021-02-09PRIORITY
EFFICACY; EfficacySUPPL14AP2022-11-08STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL3Null6
SUPPL5Null7
SUPPL7Null7
SUPPL8Null6
SUPPL9Null7
SUPPL14Null15

CDER Filings

REGENERON PHARMACEUTICALS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 761097
            [companyName] => REGENERON PHARMACEUTICALS
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761097s005lbl.pdf#page=15"]
            [products] => [{"drugName":"LIBTAYO","activeIngredients":"CEMIPLIMAB-RWLC","strength":"350MG","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"06\/25\/2020","submission":"SUPPL-5","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761097s005lbl.pdf\"}]","notes":""},{"actionDate":"03\/20\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s001lbl.pdf\"}]","notes":""},{"actionDate":"01\/18\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s002lbl.pdf\"}]","notes":""},{"actionDate":"09\/28\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761097s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"09\/28\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761097s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/761097Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/761097Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"06\/25\/2020","submission":"SUPPL-5","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761097s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/761097Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"01\/18\/2019","submission":"SUPPL-2","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761097Orig1s002ltr.pdf\"}]","notes":">"},{"actionDate":"03\/20\/2019","submission":"SUPPL-1","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761097s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761097Orig1s001ltr.pdf\"}]","notes":">"}]
            [actionDate] => 2020-06-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.